This Molecular Tumor Board presents a case of a patient with advanced stage high grade serous ovarian cancer whose OmniSeq INSIGHT testing revealed a BRCA1 mutation. Join us as we discuss next diagnostic steps, homologous recombination deficiency and treatment implications. 

Presented by:

Are you eager to hear about the latest Labcorp liquid biopsy t

Case review of a 68-year-old male with metastatic right-sided colon adenocarcinoma with KRAS A146V mutation. Frontline biomarker testing with OmniSeq INSIGHT provided initial options for therapy, but when his tumor progressed rapidly, Labcorp Plasma Focus liquid biopsy helped his oncologist determine next line of therapy.

This study investigates associations between markers of genomic instability and genomic defects in genes associated with homologous recombination (HR) in a cohort of 431 prostate cancer specimens.